Stock earnings page

ARCUS BIOSCIENCES INC (RCUS)

Track the next or latest earnings date for ARCUS BIOSCIENCES INC, review consensus estimates, and see cached AI analysis for recent quarterly results.

View this earnings week Open in the app

Recent earnings news

Arcus Biosciences, Inc. (RCUS) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript | Seeking Alpha
seekingalpha.com · 9 hours ago

Arcus Biosciences, Inc. (RCUS) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 9, 2026 10:40 AM EDTCompany ParticipantsTerry Rosen -...

Arcus Biosciences grants inducement equity awards | RCUS Stock News
www.stocktitan.net · 14 hours ago

New employee receives 2,850 options at $23.32 and 1,450 RSUs under Arcus's 2020 Inducement Plan, granted pursuant to NYSE Rule 303A.08.

What is Lifesci Capital’s Forecast for RCUS Q2 Earnings? - American Market News
www.americanbankingnews.com · 2 days ago

The stock’s fifty day moving average is $23.84 and its two-hundred day moving average is $22.85. Arcus Biosciences has a 52 week low of $7.91 and a 52 week high of $28.72. The company has a market capitalization of $2.91 billion, a PE ratio of -7.28 and a beta of 0.85. Arcus Biosciences (NYSE:RCUS –…

Arcus (RCUS) Q1 2026 Earnings Call Transcript - AOL
www.aol.com · May 5, 2026

Arcus Biosciences (NYSE:RCUS) now has full ownership of cascadifan, its lead program and primary strategic focus. Market opportunity (cascadifan) -- The company estimates a $5 billion peak sales opportunity for cascadifan in kidney cancer, with the total addressable market for renal cell carcinoma .…

Arcus Biosciences (RCUS) to Release Quarterly Earnings on Tuesday
www.marketbeat.com · April 28, 2026

Arcus Biosciences (NYSE:RCUS) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-arcus-biosciences-inc-stock/)

Latest earnings date

Feb 25, 2026

After-hours

Fiscal quarter: 2025-12-31

EPS estimate: -$0.97

Revenue estimate: N/A

Market cap: $2.93B

Analysis snapshot

No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.

Recent earnings history

Browse the calendar week

Date	Quarter	Report window	EPS est.	Revenue est.
Feb 25, 2026	2025-12-31	After-hours	-$0.97	N/A